What are the odds of experiencing a major depressive episode in your lifetime?
Evidence quality 4.88/5
Eight-dimension review score against the quality rubric . Each dimension scored 1–5.
- D1 Source grounding
- 5/5
- D2 Source authority
- 5/5
- D3 Arithmetic
- 5/5
- D4 Uncertainty
- 5/5
- D5 Scope
- 5/5
- D6 Prose
- 5/5
- D7 Perception honesty
- 4/5
- D8 Caveat completeness
- 5/5
Lifetime probability · lifetime, US adult
1 in 4.9
21% lifetime chance
Most people underestimate this.
range 1 in 6.3 to 1 in 3.3
● your factors — click this risk ▾ to reveal
≈ As likely as
Perceived
There is no standard tracker for perceived lifetime depression risk, and the question is awkwardly reflexive — asking someone to estimate their own probability of a condition partially defined by distorted self-perception. When lifetime prevalence figures are surfaced in surveys, most respondents express surprise at the 1-in-5 number. The lay mental model places "clinical depression" as something that happens to a distinct minority — perhaps 5-10% of the population — rather than to a fifth of all adults. Stigma compresses the intuitive estimate downward; so does the ordinary human tendency to classify one's own past low periods as "just being sad" rather than as episodes that would meet diagnostic criteria.
Rough estimate: most adults would guess 5-10% lifetime, roughly half the actual figure
Source: editorial intuition, not polled
Actual
20.6% lifetime prevalence (DSM-5 MDD, NESARC-III)
US adults 18+, noninstitutionalized civilian (NESARC-III, 2012-2013)
Show derivation
Uses the Hasin et al. 2018 NESARC-III estimate of 20.6% lifetime prevalence of DSM-5 major depressive disorder among US adults as the headline figure. This is a direct survey-based lifetime prevalence — no compounding or hazard conversion required. The earlier NCS-R (Kessler et al. 2003) found 16.2% lifetime under DSM-IV criteria; the upward shift reflects both the DSM-5 bereavement-exclusion removal and secular trends in reporting and detection. NIMH reports that 21.0 million US adults (8.3%) had at least one major depressive episode in the past year (NSDUH 2021), consistent with the lifetime figure given recurrence and recovery patterns. The 0.206 point estimate is bracketed by the NCS-R lower bound (~0.16) and prospective-cohort estimates that place lifetime risk as high as 0.30 when accounting for recall bias in retrospective surveys (Moffitt et al. 2010 Dunedin cohort). Uncertainty band 0.16–0.30 reflects this methodological range.
Caveats: "Major depressive episode" is defined by DSM-5 criteria: five or more symptoms d…
"Major depressive episode" is defined by DSM-5 criteria: five or more symptoms during a two-week period, including depressed mood or loss of interest/pleasure, representing a change from previous functioning. The lifetime prevalence figure captures anyone who has ever met these criteria, not current cases. Retrospective surveys undercount lifetime episodes because people forget or reframe past episodes — the Dunedin longitudinal cohort (Moffitt et al. 2010) found prospective lifetime prevalence approaching 30% by age 32, suggesting the 20.6% NESARC-III figure is likely a floor. Conversely, survey-based diagnostic instruments may overcount mild episodes that a clinician would not diagnose. The 12-month prevalence (8-10% of US adults) is the more policy-relevant number for treatment-capacity planning; the lifetime figure is the right one for answering "how common is this, really?" Depression is treatable: roughly 60% of US adults with a past-year episode received some form of treatment in 2021 per NIMH, though treatment adequacy varies widely.
Risks at similar odds
Other risks with roughly the same likelihood — useful for calibration.
Untreated depression
What fraction of US adults who develop major depression or an anxiety disorder receive no mental health treatment for at least a year?
Family caregiver probability
How likely am I to become an unpaid family caregiver — and what is the mental-health toll?
Inheriting AUD risk
If a parent had alcohol use disorder, what are the odds you'll develop alcohol use disorder yourself?
Compulsive sexual behavior
What are the odds of developing compulsive sexual behavior disorder?
Loneliness & health
What are the odds of chronic loneliness causing serious health harm over a lifetime?
Recently viewed on this device
Stored locally — clear anytime.
Pick challenger
If you or someone you know is struggling, contact the 988 Suicide & Crisis Lifeline (call or text 988) in the US, or visit findahelpline.com for international directories.
The most carefully measured estimate of lifetime major depressive disorder in the United States comes from the NESARC-III survey of 36,309 adults: 20.6%, or roughly 1 in 5. That figure, published by Hasin et al. in JAMA Psychiatry in 2018 using DSM-5 criteria, is higher than the earlier NCS-R estimate of 16.2% under DSM-IV, and almost certainly an undercount — the Dunedin longitudinal cohort, which followed participants prospectively rather than relying on recall, found prevalence approaching 30% by age 32. NIMH reports that 21 million US adults had at least one major depressive episode in the past year alone, representing 8.3% of the adult population. Depression is, by a wide margin, the most common serious mental health condition in the country, and the 1-in-5 lifetime number makes it more prevalent than a lifetime cancer diagnosis (~1 in 7 globally).
The gender gap is one of the most replicated findings in psychiatric epidemiology: lifetime prevalence runs roughly 26% for women and 15% for men, a ratio that holds across cultures, time periods, and diagnostic systems. Young adults aged 18-25 carry the highest past-year rates (18.6% per NIMH), reflecting the concentration of first-onset episodes in early adulthood. Childhood adversity roughly doubles lifetime risk, and first-degree family history roughly triples it — but the base rate is high enough that a large share of cases occur in people with no obvious predisposing factors. Nearly half of all lifetime cases are classified as severe.
What makes depression unusual in this catalogue is that it combines high prevalence with low perceived prevalence — most people dramatically underestimate how common clinical depression is, partly because stigma discourages disclosure and partly because the lay concept of “depression” is narrower than the diagnostic one. A 1-in-5 lifetime condition is not a rare disease; it is closer to the prevalence of needing glasses. The good news embedded in the NIMH data: roughly 60% of US adults with a past-year episode received some form of treatment, and treatment works — meta-analyses of antidepressants and psychotherapy both show clinically meaningful effect sizes for moderate-to-severe episodes. The population-level problem is less “we don’t know how to treat depression” and more “we underestimate how many people need treatment at any given time.”
Related tidbits
Lifetime probability of depression: 20.6% (1 in 5). Lifetime probability of cancer: ~40%. Depression affects half as many people as cancer, yet receives roughly one-tenth the research funding per patient.
About 1 in 5 US adults will experience clinical depression in their lifetime (~21%). Cancer affects roughly 40%. Both are common; only one dominates the conversation about preparedness.
1 in 5 adults will experience major depression. 1 in 12 will die of heart disease. Depression is nearly twice as common, but heart disease gets the awareness campaigns, red ribbons, and workplace AED stations.
Claim ledger
Every number below is what each source reported, with the verbatim quote we relied on and how we arrived at our figure. Click any link to verify directly.
-
[1] JAMA Psychiatry (Hasin DS, Sarvet AL, Meyers JL, et al.) — Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States
Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States- Statistic
Lifetime prevalence of DSM-5 MDD: 20.6% overall; 26.1% women, 14.7% men; 12-month prevalence 10.4% overall- Excerpt
“"Of the 36,309 participants, the lifetime and 12-month prevalences of DSM-5 MDD were 20.6% (SE, 0.4) and 10.4% (SE, 0.3), respectively... Lifetime prevalence was 26.1% among women and 14.7% among men. Most lifetime MDD cases were moderate (39.7%) or severe (49.5%)." ”
- Source data from
- 2018-04-01
- Accessed
- 2026-04-19 · archived copy
- Calculation
- NESARC-III is a nationally representative face-to-face survey of 36,309 US civilian noninstitutionalized adults aged 18+ conducted April 2012 to June 2013. Lifetime prevalence of 20.6% is used directly as the normalized figure — no hazard compounding needed because this is already a lifetime estimate. The women-to-men ratio of 26.1%/14.7% ≈ 1.78 provides the female multiplier of ~1.7. DSM-5 criteria were applied retrospectively; the removal of the DSM-IV bereavement exclusion slightly inflates prevalence relative to the earlier NCS-R estimate.
- Independence
- NESARC-III (NIAAA/NIH) is an independent nationally representative survey with its own sampling frame, field operations, and diagnostic instrument (AUDADIS-5). Fully independent from the NCS-R (Harvard/NIMH) and from NSDUH (SAMHSA).
-
[2] JAMA (Kessler RC, Berglund P, Demler O, et al.) — The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)
The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)- Statistic
Lifetime prevalence of major depressive disorder: 16.2% (95% CI 15.1-17.3); 12-month prevalence 6.6% (95% CI 5.9-7.3)- Excerpt
“"The lifetime prevalence of DSM-IV MDD was 16.2% (95% confidence interval [CI], 15.1%-17.3%), representing approximately 32.6 to 35.1 million US adults... the 12-month prevalence was 6.6% (95% CI, 5.9%-7.3%), representing 13.1 to 14.2 million US adults." ”
- Source data from
- 2003-06-18
- Accessed
- 2026-04-19 · archived copy
- Calculation
- NCS-R is a face-to-face household survey of 9,090 respondents aged 18+ conducted 2001-2002 across the 48 contiguous US states. The 16.2% figure under DSM-IV criteria is the lower bound of the uncertainty range. The gap between NCS-R (16.2%) and NESARC-III (20.6%) partly reflects DSM-5 bereavement-exclusion removal, partly secular trend, and partly methodological differences in diagnostic interview instruments (CIDI vs AUDADIS-5).
- Independence
- NCS-R (Harvard/NIMH, Kessler) and NESARC-III (NIAAA, Hasin) are fully independent epidemiologic surveys with different sampling frames, field operations, and diagnostic instruments. Agreement to within 4 percentage points across different DSM editions and a decade apart is the strongest cross-validation available for US MDD prevalence.
-
[3] National Institute of Mental Health (NIMH), NIH — Major Depression — Statistics
Major Depression — StatisticsSee all 2 Likelier entries citing this source →
- Statistic
An estimated 21.0 million US adults (8.3%) had at least one major depressive episode in the past year (2021); highest among 18-25 year olds (18.6%); females (10.3%) vs males (6.2%)- Excerpt
“"An estimated 21.0 million adults in the United States had at least one major depressive episode. This number represented 8.3% of all U.S. adults... The prevalence of major depressive episode was higher among adult females (10.3%) compared to males (6.2%)." ”
- Source data from
- 2021-12-31
- Accessed
- 2026-04-19 · archived copy
- Calculation
- NIMH republishes SAMHSA NSDUH data. The 8.3% past-year prevalence is consistent with the NESARC-III 12-month prevalence of 10.4% (NSDUH uses a screening instrument rather than a full diagnostic interview, which tends to yield slightly different estimates). The 21 million figure is the annual incidence/recurrence count; lifetime accumulation of this annual flow is what produces the 20.6% lifetime prevalence in the NESARC-III cohort study. Used as the federal government cross-check on the peer-reviewed lifetime figures.
- Independence
- NSDUH (SAMHSA) is a separate survey from both NESARC-III and NCS-R, with its own sampling design and screening instrument. The past-year estimate is consistent with but methodologically independent of the lifetime prevalence figures above.
-
[4] World Health Organization — Depressive disorder (depression) — fact sheet
Depressive disorder (depression) — fact sheet- Statistic
An estimated 3.8% of the global population experiences depression; 5% of adults globally; higher among women (6.9%) than men (4.6%)- Excerpt
“"An estimated 3.8% of the population experience depression, including 5% of adults... Depression is about 50% more common among women than among men. Worldwide, more than 10% of pregnant women and women who have just given birth experience depression." ”
- Source data from
- 2023-03-31
- Accessed
- 2026-04-19 · archived copy
- Calculation
- WHO reports point prevalence (proportion affected at any given time), not lifetime prevalence. The 5% adult point prevalence globally is consistent with US 12-month figures of 6.6-10.4% given that many episodes last less than a year and global detection rates are lower. Used here as the international cross-check on depression burden magnitude, not as the primary lifetime estimate.
- Independence
- WHO depression estimates derive from the Global Burden of Disease study (IHME) and WHO's own mental health surveys — fully independent from the US-based NESARC-III, NCS-R, and NSDUH pipelines.